chr10-96656894-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_ModerateBP6_ModerateBP7BS2
The NM_152309.3(PIK3AP1):c.471C>T(p.Asp157Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000681 in 1,614,022 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.00070 ( 1 hom., cov: 31)
Exomes 𝑓: 0.00068 ( 2 hom. )
Consequence
PIK3AP1
NM_152309.3 synonymous
NM_152309.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.70
Genes affected
PIK3AP1 (HGNC:30034): (phosphoinositide-3-kinase adaptor protein 1) Predicted to enable phosphatidylinositol 3-kinase regulatory subunit binding activity and signaling receptor binding activity. Predicted to be involved in regulation of inflammatory response; regulation of signal transduction; and toll-like receptor signaling pathway. Predicted to be located in cytoplasm and membrane. Predicted to be active in cytosol. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.45).
BP6
Variant 10-96656894-G-A is Benign according to our data. Variant chr10-96656894-G-A is described in ClinVar as [Benign]. Clinvar id is 474930.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=2.7 with no splicing effect.
BS2
High AC in GnomAd4 at 106 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PIK3AP1 | NM_152309.3 | c.471C>T | p.Asp157Asp | synonymous_variant | 3/17 | ENST00000339364.10 | NP_689522.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PIK3AP1 | ENST00000339364.10 | c.471C>T | p.Asp157Asp | synonymous_variant | 3/17 | 1 | NM_152309.3 | ENSP00000339826.5 | ||
PIK3AP1 | ENST00000371110.6 | c.-64C>T | 5_prime_UTR_premature_start_codon_gain_variant | 2/16 | 2 | ENSP00000360151.2 | ||||
PIK3AP1 | ENST00000371110.6 | c.-64C>T | 5_prime_UTR_variant | 2/16 | 2 | ENSP00000360151.2 | ||||
PIK3AP1 | ENST00000468783.1 | n.117C>T | non_coding_transcript_exon_variant | 2/8 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000697 AC: 106AN: 152052Hom.: 1 Cov.: 31
GnomAD3 genomes
AF:
AC:
106
AN:
152052
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000477 AC: 120AN: 251430Hom.: 1 AF XY: 0.000508 AC XY: 69AN XY: 135896
GnomAD3 exomes
AF:
AC:
120
AN:
251430
Hom.:
AF XY:
AC XY:
69
AN XY:
135896
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000679 AC: 993AN: 1461852Hom.: 2 Cov.: 32 AF XY: 0.000657 AC XY: 478AN XY: 727230
GnomAD4 exome
AF:
AC:
993
AN:
1461852
Hom.:
Cov.:
32
AF XY:
AC XY:
478
AN XY:
727230
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000697 AC: 106AN: 152170Hom.: 1 Cov.: 31 AF XY: 0.000565 AC XY: 42AN XY: 74388
GnomAD4 genome
AF:
AC:
106
AN:
152170
Hom.:
Cov.:
31
AF XY:
AC XY:
42
AN XY:
74388
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Infantile spasms Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 22, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at